Similar articles

• [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].

  Linde H, Lehn N. Linde H, et al. Dtsch Med Wochenschr. 2005 Mar 18;130(11):586-8; quiz 589-92. doi: 10.1055/s-2005-865067. Dtsch Med Wochenschr. 2005. PMID: 15761788 Review. German. No abstract available.
• [Clinical epidemiology of an outbreak of nosocomial infections by Staphylococcus aureus resistant to methicillin and aminoglucosides: efficacy of the measures of control].

  Parras F, Coello R. Parras F, et al. Med Clin (Barc). 1993 Sep 25;101(9):359. Med Clin (Barc). 1993. PMID: 8412405 Spanish. No abstract available.
• Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.

  Gould IM. Gould IM. Int J Antimicrob Agents. 2006 Nov;28(5):379-84. doi: 10.1016/j.ijantimicag.2006.09.001. Epub 2006 Oct 11. Int J Antimicrob Agents. 2006. PMID: 17045462 Review.
• Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2001.

  Fujino T, Mori N, Kawana A, Naiki Y, Kawahata H, Kuratsuji T, Kudo K, Kobori O, Yazaki Y, Kirikae T. Fujino T, et al. Jpn J Infect Dis. 2001 Dec;54(6):240-2. Jpn J Infect Dis. 2001. PMID: 11862007 Review. No abstract available.
• The management of the carrier of methicillin-resistant Staphylococcus aureus.

  Fekety R. Fekety R. Curr Clin Top Infect Dis. 1987;8:169-80. Curr Clin Top Infect Dis. 1987. PMID: 3077278 Review. No abstract available.